📰 Daptorum Group News
Page 2 - Daptorum Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daptorum Group. Real-time updates on events, politics, business and more.
July 29, 2023
Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the target of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 8,800 shares, a drop of 33.8% from the June 30th total of 13,300 shares. Based on an average daily trading volume, of 310,600 […]
June 22, 2023
/PRNewswire/ -- The "Global Genomics Partnering Terms and Agreements 2016 to 2023" report has been added to ResearchAndMarkets.coms offering. The Global...
June 22, 2023
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced that the group has submitted t...
June 9, 2023
Regulatory News: Aptorum Group Limited (the "Company") (NASDAQ:APM, Euronext Paris:APM) announced today that following a comprehensive review of the trading volume, costs and administrative requirements
June 9, 2023
Regulatory News: Aptorum Group Limited announced today that following a comprehensive review of the trading volume, costs and administrative requirements related to its listing on Euronext Paris,... | June 10, 2023
June 3, 2023
/PRNewswire/ -- The "Global Musculoskeletal Partnering 2016-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.coms...
May 27, 2023
Aptorum Group Limited (NASDAQ:APM – Get Rating) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 49,100 shares, a growth of 214.7% from the April 30th total of 15,600 shares. Based on an average daily volume of 308,100 shares, the days-to-cover ratio is […]
May 15, 2023
Aptorum Group (NASDAQ:APM – Get Rating) and BridgeBio Pharma (NASDAQ:BBIO – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Profitability This table compares Aptorum Group and BridgeBio Pharma’s net […]
May 14, 2023
Aptorum Group Limited (NASDAQ:APM – Get Rating) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 15,600 shares, a growth of 19.1% from the April 15th total of 13,100 shares. Based on an average daily volume of 303,800 shares, the […]